News search

    E.g., 03/04/2025
    E.g., 03/04/2025
    Enrique Lara-Pezzi, Laura Lalaguna, Benedetta Coppe, Nadia Mercader y María Galardi-Castilla.
    Research
    2 Apr 2025
    Circulation: The heart remembers: scientists describe how early-life cardiac injury in parents influences the development and function of the heart in the next generation

    Scientists at the CNIC and the University of Bern have found that heart surgery in male mice early in life creates a "memory" passed down to the next generation. Published in Circulation, the study suggests that a parental history of heart surgery should be considered when evaluating cardiovascular health in descendants.
    Research
    31 Mar 2025
    NEJM: A drug used to treat diabetes improves the prognosis of patients undergoing cardiac valve intervention

    The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients
    About the CNIC
    18 Mar 2025
    CNIC joins GRACE, a European project aimed at transforming cardiovascular care through innovation and collaboration

    The CNIC has been allocated €405,625 for its involvement in GRACE, a project focused on developing innovative strategies to improve the detection and management of cardiovascular diseases.
    Parlamento_Europeo
    About the CNIC
    14 Mar 2025
    Cardiovascular disease in women: a call for action from Europe
    Isabel Gonçalves es profesora y consultora senior en la Universidad de Lund (Suecia)
    Research
    11 Mar 2025
    Isabel Gonçalves : “Seeing patients inspires my research”

    Isabel Gonçalves is a professor and senior consultant at the University of Lun (Sweden). Her research focuses on cardiovascular disease and diabetes. She is the principal investigator in EXODIAB (Excellence in Diabetes Research in Sweden), leads a team at Cardiovascular Research - Translational Studies, and is a researcher in EpiHealth, a project focused on epidemiology for health.
    Juan De Dios Hourcade, Juan A Bernal Rodríguez, Giovanna Giovinazzo, María Beatriz Álvarez Flores, Juan Antonio López del Olmo, Valeria Caiolfa, Antonio Quesada Navidad, Lorena Cussó Mula, Manuel Desco, Fátima Sánchez Cabo, Elena Rodríguez y Ana Dopazo.
    About the CNIC
    6 Feb 2025
    The CNIC secures ISO 9001 certification for its 11 technical units

    The accreditation confirms the reliability of the units’ technical output and facilitates external collaborations, factors crucial to sustaining the CNIC’s leadership in cardiovascular research
    Gráfico explicativo
    About the CNIC
    20 Jan 2025
    The European mitochondrial lineage may protect against severe forms of COVID-19

    An international study led by Spanish research teams has identified how genetic factors can influence the severity of disease caused by SARS-CoV-2
    La investigadora Cintia Folgueira
    About the CNIC
    13 Jan 2025
    CNIC research identifies a key protein for ‘burning’ fat

    This work reveals a new mechanism by which brown fat is converted into heat, and which protects from pathologies associated with obesity.
    Ana Botín and Valentín Fuster
    About the CNIC
    19 Dec 2024
    The PESA CNIC-Santander study consolidates itself as the most important study in the world in the diagnosis and prevention of cardiovascular diseases

    The findings of this study have been key for the development of REACT, a new research project, that will count on the collaboration of Santander Bank, and will expand the study of the age group for the prevention of cardiovascular diseases, which will include 8,000 new participants.

    Macarena de Andrés Laguillo, Stefano Gambera, Sofía Sánchez Muñoz, Rui Benedito, Irene García González, Mariya Lytvyn Legin, Lourdes García Ortega, Sandra Ruiz García, Susana Ferreira da Rocha, Aroa García Cabero, Luis Diago Domingo.
    Research
    12 Dec 2024
    Nature Methods: CNIC presents iFlpMosaics, an innovative genetic toolkit for the study of gene function

    iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations.